Albendazole PCD Pharma Franchise Company

Cafoli Lifecare offers an Albendazole PCD pharma franchise to distributors and stockists throughout India. Our Albendazole portfolio runs to 10 formulations across tablets, syrup and suspension, including the Womfly brand range. All products are manufactured at WHO-GMP certified facilities, giving partners a reliable anthelmintic range for both adult and paediatric prescribing.

What is Albendazole?

Albendazole is a broad-spectrum benzimidazole anthelmintic. It binds selectively to parasite β-tubulin and blocks microtubule polymerisation, which disrupts glucose uptake and depletes the helminth's glycogen and ATP reserves, ultimately killing the parasite. It is effective against a wide range of intestinal nematodes as well as tissue-dwelling larval infections, and is included on the WHO Model List of Essential Medicines. Full pharmacological details are available at PubChem: Albendazole.

Albendazole Products Available for Franchise

These are featured presentations from a wider range of 10 formulations. Contact our team for the complete Albendazole product and price list.

Therapeutic Applications of Albendazole

Albendazole is used to treat intestinal helminth infections including ascariasis (roundworm), hookworm, trichuriasis (whipworm) and enterobiasis (pinworm), and at higher, longer-course dosing it is used in the management of neurocysticercosis and cystic echinococcosis (hydatid disease). It is also the mainstay agent in community deworming programmes.

Prescribers include paediatricians, general physicians, gastroenterologists and community health practitioners. Dosing must always be determined by the treating physician, particularly for tissue infections where extended courses are required.

Why Albendazole is a High-Potential Molecule for Distributors

Soil-transmitted helminth infection remains widespread in India, and albendazole sits at the centre of the national deworming effort — single-dose deworming is delivered to school-age children through government programmes, which keeps public awareness of the molecule unusually high and drives private-market demand alongside it. For a distributor, the practical advantage is breadth: the same molecule sells as a paediatric syrup and suspension through paediatricians and as tablets through general practice, so one line covers two very different prescriber bases. Deworming is also periodic rather than one-off, which builds a predictable repeat cycle rather than depending on outbreaks.

Why Choose Cafoli Lifecare

Cafoli Lifecare provides monopoly distribution rights by district or territory, WHO-GMP certified manufacturing and DCGI-approved products. Partners receive comprehensive promotional inputs — visual aids, samples, product cards, MR bags and prescription pads — with transparent pricing and prompt dispatch. We already work with 1000+ franchise partners nationwide.

References

1. PubChem Compound Summary – Albendazole
2. WHO Model List of Essential Medicines
3. PubMed – Albendazole in soil-transmitted helminthiasis